We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Saturday
May 16
08:45 - 09:45
Poster Area
Breast cancer
Poster Highlights
Clinical
Stereotactic Accelerated Partial Breast Irradiation Using CyberKnife – 5-Year Results of a single-institution Phase II trial.
Norbert Mészáros, Hungary
-1003
PRE-ACT-01: an international, multicenter, randomized study on communicating a personalized AI-based lymphedema risk to breast cancer patients
Sofia Rivera, France
-1525
Continuous positive airway pressure in breast cancer radiotherapy: preliminary results from a prospective clinical trial
Aline Van der Vorst, Belgium
-1533
Breast cancer: Exploring the impact of radiotherapy-dose in muscles on treatment-induced arm morbidity
Lotte Veldt, The Netherlands
-1557
ESTRO’s FALCON breast cancer target volume contouring workshops: Where are we in 2025?
SENEM ALANYALI, Turkey
-1735
Surgery de-escalation in patients with pathologic complete response after neoadjuvant therapy: comparison with matched retrospective groups.
Sergey Novikov, Russian Federation
-2009
Quantifying 20 Years of Breast Cancer Survival Gains in Singapore: A Multivariable Analysis
Fuh Yong Wong, Singapore
-2056
Predictors of cardiotoxicities after hypo-fractionated whole breast radiotherapy: dependence on the type of cardiac event
Alfonso Belardo, Italy
-2166
Prolonging breath-hold duration in radiotherapy using cognitive engagement
Vincent Huybrechts, Belgium
-2177
Toxicity and cosmetic outcomes of ultra-hypofractionated whole-breast irradiation with simultaneous integrated boost after breast-conserving surgery
Emilie Natier, France
-2235
Updated Follow-up of SBRT as Primary Treatment in Breast Cancer Patients Unfit for Surgery
INES OLLINGER, Spain
-2322
Nodal response after neoadjuvant systemic therapy: are we missing internal mammary lymph node metastases?
Johannes Elias Wider, Germany
-2363
SBRT in Combination with Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer: A Multinational Cohort Study
Marcin Kubeczko, Poland
-2416
Ultra-Hypofractionation vs Hypofractionation in Post-Mastectomy Radiotherapy (PMRT): A Prospective Randomized Dosimetric and Clinical Comparison Study
Meghal Prajapati, India
-2596
Sexual dysfunction in long-term breast cancer survivors: Insights from a LMIC country
Nejla Fourati, Tunisia
-2603
Adjuvant ultra-hypofractionated radiotherapy for early-stage breast cancer: toxicity and quality of life results
Paola Puccini, Italy
-2824
Stereotactic body radiotherapy in patients with bone oligometastases from breast cancer – results from a european multicenter cohort study
Franziska Nägler, Germany
-2877
Simultaneous bilateral breast irradiation (SBBI) in synchronous bilateral breast cancer (SBBC): experience from two German university hospitals
Polina Yaremenko, Germany
-3346
Safety of sacituzumab govitecan and concomitant radiation therapy in triple negative breast cancer: an international retrospective cohort study
Luca Visani, Italy
-3895
Stereotactic radiotherapy and novel drugs for brain metastases from breast cancer: RABBIT-NEW TRIAL, an observational multicentric retrospective study
Silvia Scoccianti, Italy
-4312
Toxicity and compliance to adjuvant concurrent chemo-radiotherapy for breast cancer: initial data from a randomized trial.
tabassum wadasadawala, India
-4467
Pathological response in pre-operative stereotactic radiotherapy in early-stage breast cancer: systematic review and meta-analysis
Giuseppe Facondo, Italy
-4554
Cost-Effectiveness Analysis of Ultrahypofractionated vs Moderately Hypofractionated Whole Breast Radiotherapy: A Canadian Perspective
Ammar Salkini, Canada
-4598
Safety and Tolerance of Adjuvant Radiotherapy after Oncoplastic Breast Surgery: Impact of Monolateral vs Bilateral Procedures
Edy Ippolito, Italy
-4608
Boosting breast cancer detection: The impact of AI in mammography screening
Nejla Fourati, Tunisia
-4743
Five-Year Outcomes of Preoperative Concurrent Chemoradiotherapy in HER2-Positive and Triple-Negative Breast Cancer
Raquel Ciervide, Spain
-4801
Real-world feasibility and cardiac sparing with ABC-DIBH across different fractionation regimens in left-sided breast radiotherapy: BRAVE-HEART trial
Elisabetta Bonzano, Italy
-4922
Canadian physician attitudes toward sentinel lymph node biopsy omission in early-stage breast cancer: implications for radiotherapy planning
Jean-Marc Bourque, Canada
-4923
Intraoperative radiotherapy for breast cancer using the papillon+ system: 5-year results update
Flora COURTAULT-DESLANDES, France
-4996
Predictors for LRR in early breast cancer patients with isolated tumor cells and micro/macro metastases treated with BCS, SLNB followed by adjuvant RT
Kurian Joseph, Canada
-674
Breast Reirradiation Practice Patterns: An International Survey from the Reirradiation Collaborative Group (ReCOG)
Dorota Gabrys, Poland
-712
Imaging Characteristics and Clinical Significance of Incidental Axillary Lymph Nodes on Radiotherapy Planning Tomography in Breast Cancer Patients
Meltem Kirli Bolukbas, Turkey
-863
Phase I study to evaluate the safety and tolerability of SABR treatment in inoperable breast cancer: final results
CAROLINA DE LA PINTA, Spain
-921
Subclinical atherosclerosis: Risk marker for post-radiotherapy breast edema?
Ana Diaz-Gavela, Spain
-929